Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Disease area: Paediatric lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Polycarpou, S. Zachaki, N. Polycarpou, S. Gavrili, C. Kostalos (Athens, Greece). L-arginine for chronic lung disease (CLD) in preterm neonates. Eur Respir J 2013; 42: Suppl. 57, 2056

Member's Comments

No comment yet.

Related content which might interest you: Alterations of exhaled nitric oxide in pre-term infants with chronic lung disease Source: Eur Respir J 2007; 29: 251-258 Year: 2007 Exhaled nitric oxide output is decreased in preterm infants with chronic lung disease in the post-acute phase Source: Eur Respir J 2004; 24: Suppl. 48, 464s Year: 2004 Alveolar nitric oxide (NO) in children born extremely preterm (EP) Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children Year: 2014 Association of peripheral eosinophilia with chronic neonatal lung disease in preterm babies Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments Year: 2016 Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Factors that predict length of home oxygen supplement in children with chronic lung disease of prematurity (CLD) Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Fractional exhaled nitric oxide concentration in school-aged children born who had chronic lung disease in infancy Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018 Nitric oxide in acute testing in patients with pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Inhaled nitric oxide (iNO) in patients with acute cor pulmonale due to acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Pulmonary hypertension in patients with COPD Source: Eur Respir Mon 2012; 57: 138-147 Year: 2012 Exhaled breath condensate: Measuring inflammation and oxidative stress in preterm infants Source: International Congress 2016 – Origins of infant pulmonary disease: early pointers for identifying infants at risk and ways to improve their care Year: 2016 Inhaled nitric oxide in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2006; 28: Suppl. 50, 399s Year: 2006 Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled nitric oxide and postnatal dexamethasone in chronically ventilator dependent, preterm infants Source: Eur Respir J 2002; 20: Suppl. 38, 532s Year: 2002 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010